Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
August 26, 2025
From CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
August 26, 2025
From CNBC.com News
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
August 24, 2025
From CNBC.com News
From CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
August 19, 2025
From CNBC.com News
Home Depot disappoints, Novo Nordisk's GLP-1 updates, an AI warning and more in Morning Squawk
August 19, 2025
From CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
August 18, 2025
From CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
August 07, 2025
From CNBC.com News
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
August 07, 2025
From CNBC.com News
Wegovy maker Novo Nordisk's sales hike in second quarter
August 06, 2025
From CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
August 05, 2025
From CNBC.com News
Hims & Hers stock falls 10% on revenue miss
August 04, 2025
From CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
August 01, 2025
From CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
August 01, 2025
From CNBC.com News
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
July 31, 2025
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Europe’s most valuable firm SAP flags U.S. trade slowdown but says Japan deal gives 'hope'
July 23, 2025
From CNBC.com News
From CNBC.com News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
July 16, 2025
From CNBC.com News
From CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
July 08, 2025
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Tuesday
June 24, 2025
From CNBC.com News
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.